Trial Profile
Intravitreal Ranibizumab or Triamcinolone Acetonide in Combination With Laser Photocoagulation for Diabetic Macular Edema.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 May 2021
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary) ; Triamcinolone (Primary)
- Indications Diabetes mellitus; Diabetic macular oedema
- Focus Therapeutic Use
- Acronyms LRT for DME; PROTOCOL J
- 07 Apr 2014 Trial status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Dec 2012 Planned end date changed from 1 Mar 2012 to 1 Mar 2013 as reported by ClinicalTrials.gov.
- 09 Dec 2011 Primary endpoint identified (optical coherence tomography outcomes) as reported by ClinicalTrials.gov.